1981-2008 YILLARI ARASINDA MİNNESOTA ÜROLİT MERKEZİNE GÖNDERİLEN KÖPEK İDRAR TAŞLARININ KANTİTATİF ANALİZİ

Öz

1981 ile 2008 yılları arasında köpeklerden elde edilen idrar taşları, kantitatif mineral analizi için Minnesota Ürolit Merkezi’ne gönderildi. Ürolitlerin mineral yapısı önemli bir şekilde değişti. 1981 yılında magnezyum amonyum fosfat (MAP) baskın iken kalsiyum oksalat çok nadirdi. Fakat takip eden yıllarda kalsiyum oksalat görülme oranı arttı ve MAP görülme görülme oranı azaldı. 2008 yılındaki toplam 42.885 ürolitlerin %41’ini kalsiyum oksalat oluştururken, %39’unu MAP oluşturdu. Kalsiyum oksalat ve MAP ile mukayese edildiğinde, diğer biyojenik minerallerin idrar taşlarındaki görülme oranlarında çok az değişiklik vardı. Bu 27 yıllık sürede MAP görülme oranınındaki hızlı azalma ve kalsiyum oksalat görülme oranındaki hızlı artış; bu değişikliklerdeki önemli risk faktörleri olarak ırk, yaş ve cinsiyet demografik faktörlerinden daha ziyade yaşam şartları, su ve besin kaynakları ve sosyoekonomik statü çevresel faktörlerinin etken olduğunu gösterir

Anahtar Kelimeler

• Ürolit, kalkulus, taş, ürolit analizi

Quantitative Analysis of Canine Uroliths Submitted to the Minnesota Urolith Center: 1981 to 2008

Öz

Uroliths retrieved from dogs between 1981 and 2008 were submitted to the Minnesota Urolith Center for quantitative mineral analysis. The type of minerals found in uroliths significantly changed. phosphate (MAP) was the predominant mineral type. Calcium oxalate was very uncommon. However, during subsequent years the frequency of calcium oxalate increased, and the frequency of struvite uroliths decreased. In 2008, calcium oxalate comprised 41% of 42,885 uroliths and MAP comprised 39% of 42,885 uroliths. Compared to calcium oxalate and MAP, there were only small changes in the frequency of other biogenic minerals in uroliths. The rapid rate of decline in the frequency of MAP and the rapid rate of increase of calcium oxalate over this 27-year period implicates environmental (living conditions, sources of food and water and socioeconomic status) rather than demographic (breed, age, gender) as major risk factors for these changes

Anahtar Kelimeler

• Urolith, calculus, stone, urolith analysis

Kaynakça

1. Osborne CA, Lulich JP, Polzin DJ, et al. Analysis of 77,000 canine uroliths: Perspec- tive from the Minnesota Urolith Center Vet Clin North Am Sm Anim Pract 1999; 29:17– 38.
2. Osborne CA, Lulich JP. Risk and protective factors for urolithiasis. What do they mean? Vet Clin North Am Small Anim Pract 1999; 29:39–41.
3. Tarttelin MF. Feline struvite urolithiasis: Factors affecting urine pH may be more im- portant than magnesium levels in food. Vet Rec 1987; 121:227-230.
4. Taton GF, Hamar DW, Lewis LD. Urinary acidification in prevention and treatment of feline struvite urolithiasis. J Am Vet Med As- soc 1984; 184:437-443.
5. Osborne CA, Sanderson SL, Lulich JP, et al. Canine cystine urolithiasis: Cause, detection, treatment, and prevention. Vet Clin North Am Small Anim Pract 1999; 29:193–211.
6. Bartges JW, Osborne CA, Lulich JP, et al. Methods for evaluating treatment of uroliths. Vet Clin North Am Small Anim Pract 1999; 29:45–57.
7. Ulrich LK, Bird KA, Koehler LA, et al. Urolih Analysis: Submission, Methods, and Interpre- tation. Vet Clin North Am Sm Anim Pract 1996; 26: 393 – 400.
8. Albasan H, Osborne CA, Lulich JP, Lek- charoensuk C, Koehler LA, Ulrich LK, Swan- son LL. Rate and frequency of recurrence of uroliths after an initial ammonium urate, cal- cium oxalate, or struvite urolith in cats. J Am Vet Med Assoc 2009; 235:1450-1455.

9. Cannon AB, Westropp JL, Ruby AL, et al. Evaluation of trends in urolith composition in cats: 5,230 cases (1985-2004). J Am Vet Med Assoc 2007; 231:570-576.
10. Leckharoensuk C, Lulich JP, Osborne CA, et al. Association between patient-related factors and risk of calcium oxalate and magnesium ammonium phosphate urolithiasis in cats. J Am Vet Med Assoc 2000; 217:520–25.
11. Houston DM, Moore AEP. Canine and feline urolithiasis: Examination of over 50,000 uro- lith submissions to the Canadian Veterinary Urolith Centre from 1998 to 2008. Can Vet J 2009; 50:1263-1268.
12. Low WW, Uhl JM, Kass PH, et al. Evaluation of trends in urolith composition and charac- teristics of dogs with urolithiasis: 25,499 cas- es (1985–2006). J Am Vet Med Assoc 2010; 236:193–200.
13. Goldfarb S. Dietary factors in the pathogene- sis and prophylaxis of calcium nephrolithiasis. Kidney Int 1988; 34:544-555.
14. Osborne CA, Poffenbarger EM, Klausner JS, et al. Etiopathogenesis, clinical manifesta- tions, and management of canine calcium oxa- late urolithiasis. Vet Clin North Am Sm Anim Pract 1986; 16:133–170.
15. Lulich JP, Osborne CA, Thumchai R, et al. Epidemiology of canine calcium oxalate uro- liths: Identifying risk factors. Vet Clin North Am Sm Anim Pract 1999; 29:113–122.
16. Lulich JP, Osborne CA, Lekcharoensuk C, et al. Canine calcium oxalate urolithiasis: Case based applications of therapeutic principles. Vet Clin North Am Sm Anim Pract 1999; 29:123–139.
17. Osborne CA, Kruger JM, Lulich JP, et al. Feline urologic syndrome; feline lower uri- nary tract disease; feline interstitial cystitis: what’s in a name? J Am Vet Med Assoc 1999; 214(10):1470–80.
18. Zuckerman JM, Assimos DG. Hypocitraturia: Pathophysiology and medical management. Rev Urol 2009; 11:134-144.
19. Polzin DJ, Osborne CA. Canine distal renal tubular acidosis and urolithiasis. Vet Clin North Am Sm Anim Pract 1986; 16:241–250.
20. Osborne CA, Bartges JW, Lulich JP, et al. Canine purine urolithiasis: Causes, detection, management and prevention. In: Hand MS, Thatcher CD, Remillard RL, Roudebush P, Novotny BJ, eds. 5th ed. Small Animal Clini- cal Nutrition. Topeka, KS: Mark Morris Insti- tute, 2010;833-853.
21. Lonsdale K. Human stones. Science 1968; 159:199–207.
22. Mandel NS, Mandel GS. Urinary tract stone disease in the United States veteran popula- tion II. Geographical analysis of variations in composition. J Urol 1989; 1432:11516–21.
23. Robertson WG, Peacock M, Heyburn PJ. Should recurrent calcium oxalate stoneform- ers become vegetarians? Br J Urol 1979; 51:427–31.